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Abstract
Background: The two major indications for tonsillectomy are recurrent tonsillitis (RT) and peritonsillar abscess (PTA). Unlike
PTAs, which are primarily treated surgically, RT is often cured by tonsillectomy only after a series of failed drug therapy
attempts. Although the bacteriological background of RT has been studied, the reason for the lack of success of
conservative therapeutic approaches is not well understood.
Methods: In a prospective study, tonsil specimens from 130 RT patients and 124 PTA patients were examined for the
presence of extra- and intracellular bacteria using antibiotic protection assays. Staphylococcus aureus isolates from RT
patients were characterized by pulsed-field gel electrophoresis (PFGE), spa-typing and MSCRAMM-gene-PCR. Their ability for
biofilm formation was tested and their cell invasiveness was confirmed by a flow cytometric invasion assay (FACS),
fluorescent in situ hybridization (FISH) and immunohistochemistry.
Findings: S. aureus was the predominant species (57.7%) in RT patients, whereas Streptococcus pyogenes was most prevalent
(20.2%) in PTA patients. Three different assays (FACS, FISH, antibiotic protection assay) showed that nearly all RT-associated
S. aureus strains were located inside tonsillar cells. Correspondingly, the results of the MSCRAMM-gene-PCRs confirmed that
87% of these S. aureus isolates were invasive strains and not mere colonizers. Based upon PFGE analyses of genomic DNA
and on spa-gene typing the vast majority of the S. aureus isolates belonged to different clonal lineages.
Conclusions: Our results demonstrate that intracellular residing S. aureus is the most common cause of RT and indicate that
S. aureus uses this location to survive the effects of antibiotics and the host immune response. A German translation of the
Abstract is provided as supplementary material (Abstract S1).
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Introduction
Although clearly differing in course of disease, clinical
symptoms, and prognosis, RT and PTA have several common
aspects: they are comparatively frequent diseases among otolar-
yngology patients, predominantly or even exclusively caused by
bacteria, and despite the possible administration of antibiotics they
are successfully managed by surgical measures. Whereas ‘‘a
chaud’’ bilateral tonsillectomy and drainage is the method of
choice for treating PTA patients [1,2], RT patients are
recommended to undergo surgery when experiencing more than
three episodes per year despite adequate antibiotic therapy [3].
Comparably successful treatment regimens for both infections
could be due to a similar etiology. In fact, a number of studies have
been conducted to elucidate the spectra of bacteria involved in
causing PTA or RT. Haemophilus influenzae, Staphylococcus aureus, and
Streptococcus pyogenes were - with varying relative proportions - the
predominant species isolated from both patient groups (PTA:
[4–9]; RT: [10–26]). Specifically in PTA patients, anaerobes were
frequently found to accompany the aforementioned species. While
the bacteriologicalspectra of PTA patient specimensweregenerally
reported without comparison to other patient groups, data from
RT patients were compared with data from healthy persons or
patients undergoing tonsillectomy because of tonsillar hypertrophy
[4,14,17–19]. Astonishingly little differences were seen between
these groups of patients. In RT patients, also the efficiency of
different approaches for material collection was compared by
employing superficial swabs from the tonsillar surface or the
pharyngeal wall vs. fine needle aspirations or surgically prepared
tonsillar core [12–16,21,23,24,26]. With the exception of Haemoph-
ilus influenzae more frequently isolated from the tonsillar core, again
little differences could be established between the compared
groups. Yet, to our best knowledge a direct comparison of the
local microflora in PTA and RT patients utilizing both surface
swabs and surgical specimens has not been performed so far.
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antibiotic therapy still remains unclear. Low concentrations of the
antibiotics in the tonsillar tissue, potentially combined with the
presence of resident bacteria producing protective enzymes, or
specific antibiotic resistance patterns of the involved pathogenic
bacteria have been presented as explanations [27]. In addition, the
localization of the causative agents in superficial biofilms or inside
the tonsillar tissue could contribute to functional antibiotic
resistance in spite of absent specific resistance mechanisms [28–
32]. While an intracellular localization of S. pyogenes in tonsillar
cells and an associated resistance to b-lactam antibiotics is
generally accepted based on few ex vivo and numerous in vitro
studies [33,34], much less is known about the role of intracellular
S. aureus in upper respiratory tract infections. Generally, S. aureus
has been demonstrated to internalize with varying efficiency into
non-professional human phagocytes [35,36], but so far was
described as an intracellular resident in only few patients with
recurrent rhinosinusitis [37,38].
Invasion of S. aureus is influenced by a broad variety of virulence
factors, especially adhesins or so called ‘‘microbial surface components
recognizing adhesive matrix molecules’’ (MSCRAMMS). Staphylo-
coccal adhesion to host cells is often mediated through binding to
bridging matrix molecules, which are likewise bound by the host cells
via specific receptors like b1-integrins [35]. Certain invasive S. aureus
strains express for example two fibronectin binding proteins (FnbpA/-
B), three proteins for fibrinogen binding: clumping factor A and B
(ClfA/-B) and fibrinogen binding protein (Fib) [39,40]. MSCRAMMS
for bone sialoprotein (bone sialoprotein binding protein–Bbp) and
collagen (collagen binding protein–Cna) are associated with osteomy-
elitis and arthritis. Further adhesins, which are common in invasive
isolates, are for example elastin binding protein (Ebp) and laminin
binding protein (Eno) [39]. Since the most Staphylococcus caused diseases
are not associated with the expression of single ‘‘typical’’ toxins like
toxic shock syndrome toxin, epidermolytic toxins or enterotoxins it was
assumed that the combination of a number of factors especially
MSCRAMMs during the infective process determines the invasive
character of a certain strain [40].
One strategy to evade humoral immunity and the effects of
several antibiotics is persistence in the cellular interior. So S. aureus
has evolved several mechanisms for intracellular persistence. After
attaching to host cells via MSCRAMMs S. aureus is internalized
through clathrin-coated pits following the rearrangement of the
cytoskeleton [35]. Staphylococcal invasion is typically associated
with the induction of apoptosis and in consequence with the death
of tissue (necrosis), but it has also been demonstrated that S. aureus
has the capability to upregulate cytoprotective or antiapoptotic
factors to establish an intracellular carrier state [41]. For example,
it was shown that S. aureus is able to prevent staurosporine-induced
apoptosis by downregulating the cytochrome c release with
subsequent caspase-3 activation after its engulfment by macro-
phages [41]. Some S. aureus strains adopted to intracellular
environments present an altered metabolism and a reduced
production of virulence factors. These strains sometimes grow very
slow in small non-pigmented colonies. That’s why there were
referred to as small colony variants (SCV) [35].
Thus, defining the most prominent bacterial species in RT
patients as compared to PTA patients and elucidating the
preferred site at which these bacteria persist in between the
infection periods could help to develop new strategies for a
successful therapy besides the well established but, considering e.g.
post-surgical hemorrhages, potentially harmful tonsillectomy [42].
Therefore, swabs and surgically removed specimens from RT and
PTA patients and a large panel of complementing methods were
used for a prospective and comprehensive study of the involved
bacterial species and their precise anatomical location.
Here, we show that S. aureus is the predominant species in RT
patients. According to our results, long term persistence is likely
due to an intracellular location rather than biofilm formation. This
feature was not associated with a single, especially successful clone
but with a wide variety of strains even when looking at a locally
restricted group of patients. The antibiotic resistance patterns of
the RT-associated isolates did not significantly differ from other
outpatient S. aureus isolates and thus, did not offer a straightfor-
ward conservative approach to eradicate the bacteria from their
intracellular asylum.
Results
Patient Data
Age and gender ratio of the 130 RT patients and the 124 PTA
patients are listed in table 1. The mean age of PTA patients was 11
years higher than in the RT group. Similarly, the median age of
children among the PTA patients was 16 years as opposed to 8.5
years among the RT patients. These differences were highly
significant. Thus, PTA occurred more frequently in adolescents
and adults whereas RT was more frequent in children and
younger adults. According to our data female patients predom-
inated in the RT group, whereas the gender ratio was more
balanced in the PTA group (table 1).
All RT patients showed the typical clinical signs of tonsillar
hypertrophy (grade: 1: 9.2%; 2: 50.0%; 3: 40.8%) and tonsillar
fixation (grade 1: 30.3%; 2: 57.9%; 3: 11.8%). Clefted tonsils,
cervical lymphadenopathia and tonsillar exsudate were quite
common symptoms among the S. aureus RT patients. In contrast,
abcess formation and tonsillar erythema were remarkably rare
among them (table 2).
Detection of Bacterial Pathogens
Table 3 lists the results of the culture techniques applied on the
tonsillar material prior to exposure to antibiotics. Neisseria sp., a-
Table 1. General caracteristics of the study population.
RT PTA
Characteristics Childrenn=44 Adults n=86 All n=130
Children
n=21 Adults n=103 All n=124 p-value All/All
Age (mean) yrs 8.865.0 29.1610.0 22.3612.9 13.763.6 36.9615.8 33.0616.9 0.0000
Age (median) yrs 8.564.5 27.068.2 20.0610.4 16.062.8 34.0613.1 28.0613.9
Male sex n (%) 14 (31.8) 34 (39.5) 48 (36.9) 12 (57.1) 58 (56.3) 70 (56.5) 0,0025
*
Naccording to Wilcoxon-Mann-Whitney-U-Test.
doi:10.1371/journal.pone.0009452.t001
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patient
Hypertrophy
grade
Tonsillar
fixation
Tonsillar
erythemia
Clefted
tonsils abscess
cervival lymph-
adenopathy
pus/exsudate
detritus
G64I 2 1 2 + 22 +
A56 3 1 2 + 22 +
A54 3 1 2 + 22 +
G64II 2 1 2 + 22 +
A57 2 2 22 2 + 2
G57 3 1 2 + 2 + 2
A55 2 1 2 + 22 +
A13 1 2 2 + 22 2
A22 3 3 2 + 2 + 2
G72 3 1 2 + 2 + 2
G88 3 2 2 + 2 ++
A41 2 3 2 + 2 + 2
G32 2 1 2 + 2 ++
G20 2 2 2 + 2 + 2
A05 2 2 2 + 2 + 2
A34 2 2 2 + 22 +
A20 1 2 2 + 22 2
G71 3 1 2 + 2 ++
G46 2 1 2 + 22 2
G47 2 1 2 + 22 2
G36 2 2 2 + 22 +
G53 3 2 2 + 22 2
G61 2 2 2 + 22 2
A07 3 2 22 2 + 2
G80 3 1 2 + 2 + 2
G90 3 2 2 + 2 ++
G43 2 2 2 + 22 2
G91 2 2 2 + 22 +
A27 3 3 2 + 2 ++
G14 2 2 2 + 22 2
A03 2 2 2 + 22 +
A15 1 2 22 + 22
G29 2 2 2 + 2 ++
A36 1 2 2 + 22 2
G12 3 2 2 + 2 + 2
G11 2 1 2 + 2 + 2
G07 3 2 2 + 22 2
G21 2 2 2 + 22 2
G30 3 1 2 + 2 ++
G09 2 2 2 + 2 ++
G51 3 2 2 + 22 +
A35 2 2 2 + 22 2
G49 3 1 2 + 2 + 2
A14 3 2 22 2 2 2
G10 1 1 2 + 22 +
G77 3 2 2 + 22 2
G75 3 1 2 + 2 + 2
G45 3 2 2 + 22 +
S. aureus Caused Tonsillitis
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typical members of the resident microflora in the upper respiratory
tract are not listed in this table. Notably, there were 31 PTA
patients (25.8%) but only one RT patient (0.7%), which exclusively
presented typical microflora of the upper respiratory tract.
In the RT group, the most prevalent pathogenic bacterial
species was S. aureus (75 patients; 57.7%; P,0.001), whereas in the
PTA group S. pyogenes had this status (25 patients; 20.2%; P=0.12).
Remarkably, Haemophilus influenzae (23.1% vs. 1.6%; P,0.001),
Haemophilus parainfluenzae (32.3% vs. 1.6%; P,0.001) and Candida
sp. (14.6% vs. 4.8%; P=0.0108) occurred predominantly in the
RT group. The same differences and significance levels were seen
when comparing children and adults between both patients
groups. Consistently, when matching the results from children and
adults within each patient group, no significant differences were
apparent, with the exception of H. parainfluenzae which was
preferentially isolated from adults of the RT group (p=0.0479).
Table 4 details the microorganisms co-isolated from the 75 S.
aureus positive RT-patients. In about one fifth of such patients (13
persons) S. aureus was the only pathogenic agent. Besides S.
anginosus and S. constellatus, H. parainfluenzae and H. influenzae
predominated among the potentially pathogenic bacterial species
accompanying S. aureus, while S. pyogenes and S. aureus co-existed in
only one patient. Again, there were no significant differences
between the age groups among the RT patients.
S. aureus was most frequently detected in both extracellular and
intracellular reservoirs in the tonsils (figure 1). However, in tonsils
of 4 RT patients S. aureus was cultured exclusively extracellular,
i.e., before in vitro exposure to antibiotics. In contrast, tonsil
material of only two RT patients appeared to be sterile, but S.
aureus was cultured from the intracellular compartment with the
antibiotic protection assay, indicating an exclusively intracellular
localization of the bacteria.
One S. aureus isolate (G86) grew in tiny, nonpigmented,
nonhemolytic colonies typical for a small colony variant but
reverted immediately after one passage to the normal morphotype.
Susceptibility testing data. Table 5 compares the antibiotic
susceptibility patterns of the 76 S. aureus isolates from the RT
patients with S. aureus isolates of 296 outpatients from the Health
Centers of the departments of otolaryngology, ophthalmology and
patient
Hypertrophy
grade
Tonsillar
fixation
Tonsillar
erythemia
Clefted
tonsils abscess
cervival lymph-
adenopathy
pus/exsudate
detritus
G62 2 3 2 + 22 2
G50 3 2 2 + 22 +
G76 2 2 2 + 22 +
G27 3 1 2 + 22 2
G41 3 2 2 + 22 +
A37 2 2 2 + 2 + 2
G22 2 3 + 22 + 2
G06 2 2 2 + 2 + 2
A12 3 1 22 2 2 2
G31 2 2 2 + 2 ++
G78 2 2 2 + 2 + 2
A26
1 23 2 ++ 2 +
G19 2 2 2 + 22 2
A02 3 2 2 + 2 ++
A04 1 3 2 + 22 +
A43 3 1 2 + 2 ++
A33 3 3 2 + 2 ++
G04 2 2 2 + 2 + 2
G55 1 1 2 + 22 2
G56 2 2 2 + 22 +
A42 3 2 2 + 2 + 2
G86
2 22 2 + 2 + 2
G84 2 2 2 + 22 2
A44 3 1 2 + 2 ++
A39 2 3 2 + 2 + 2
A17 2 2 2 + 22 +
G35 2 1 2 + 2 ++
G87 3 2 2 + 22 2
% positive 100 100 1.3 92.1 2.6 46.1 43.4
Signs and symptoms were graded as ‘‘0’’–none, ‘‘1’’–poor, ‘‘2’’–moderate. ‘‘3’’–strong).
doi:10.1371/journal.pone.0009452.t002
Table 2. Cont.
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between 2001 and 2007. In general, there were no significant
differences for all the tested antibiotics.
Only from one 29 year old female RT patient a methicillin-
resistant S. aureus strain was isolated. All other strains were
susceptible to oxacillin, cefuroxime, levofloxacin, moxifloxacin and
gentamycin. All strains including the MRSA-isolate were suscep-
tible to vancomycin, teicoplanin, cotrimoxacol and clindamycin.
FACS-based eukaryotic cell internalization. The results
of the FACS-based internalization assays are presented in figure 1
Table 3. Distribution of potentially pathogenic microorganisms isolated from RT and PTA patients.
RT PTA p-value
Bacterial species Children n=44
Adults
n=86
All
n=130
Children
n=21
Adults
n=103
All
n=124
RT/PTA
All/All
Staphylococcus aureus
MRSA
a
SCV
b
29 (65.9)
0( 0 )
0( 0 )
46 (53.5)
1 (1.2)
1 (1.2)
75 (57.7)
1( 0 . 8 )
1( 0 . 8 )
4 (19.0)
0( 0 )
0( 0 )
6 (5.8)
0 (0)
0 (0)
10 (8.1)
0( 0 )
0( 0 )
0.0000
1.0000
1.0000
Streptococcus agalactiae 3 (6.8) 4 (4.7) 7 (5.4) 0 (0) 3 (2.9) 3 (2.4) 0.3353
Streptococcus anginous 4 (9.1) 18 (20.9) 22 (16.9) 1 (4.8) 9 (8.7) 10 (8.1) 0.3810
Streptococcus constellatus 7 (15.9) 25 (29.1) 32 (24.6) 3 (14.3) 19 (18.5) 22 (17.7) 0.2200
Streptococcus dysgalactiae
ssp. equisimilis
1 (2.3) 3 (3.5) 4 (3.1) 1 (4.8) 1 (1.0) 2 (1.6) 0.6843
Streptococcus pneumoniae 1 (2.3) 0 (0) 1 (0.8) 0 (0) 2 (1.9) 2 (1.6) 0.6148
Streptococcus pyogenes 7 (15.9) 9 (10.5) 16 (12.3) 7 (33.3) 18 (17.5) 25 (20.2) 0.1240
Haemophilus influenzae 14 (31.8) 16 (18.6) 30 (23.1) 0 (0) 2 (1.9) 2 (1.6) 0.0000
Haemophilus parainfluenzae 9 (20.5) 33 (38.4) 42 (32.3) 1 (4.8) 1 (1.0) 2 (1.6) 0.0000
Eikenella sp. 0 (0) 0 (0) 0 (0) 1 (4.8) 1 (1.0) 2 (1.6) 0.2373
Capnocytophaga sp 1 (2.3) 1 (1.2) 2 (1.5) 0 (0) 4 (3.9) 4 (3.2) 0.4378
Enterobacteria 0 (0) 1 (1.2) 1 (0.8) 0 (0) 2 (1.9) 2 (1.6) 0.6148
Burkholderia cenocepacia 2 (4.5) 1 (1.2) 3 (2.3) 0 (0) 0 (0) 0 (0) 0.2475
Anaerobes
c -
d -
d -
d 8 (38.1) 30 (29.1) 38 (30.6) -
Candida sp. 8 (18.2) 11 (12.8) 19 (14.6) 1 (4.8) 5 (4.9) 6 (4.8) 0.0108
aMethicillin-resistant Staphylococcus aureus: Oxacillin MIC $4 mg/ml.
bsmall colony variant.
cpredominantly Prevotella sp., Bacteroides sp. or Fusobacterium sp.
dmethods for detection not included in the study protocol.
doi:10.1371/journal.pone.0009452.t003
Table 4. List of potentially pathogenic microorganisms co-isolated with S. aureus in RT patients.
RT n (%)
Bacterial species Children n=29 Adults n=46 p-value Childen/Adults All n=75
only Staphylococcus aureus
a 5 (17.2) 8 (17.4) 1.0000 13 (17.3)
second Staphylococcus aureus 0 (0) 1 (2.2) 1.0000 1 (1.3)
Streptococcus agalactiae 3 (10.3) 2 (4.3) 0.3687 5 (6.7)
Streptococcus anginous 4 (13.8) 12 (26.1) 0,2561 16 (21.3)
Streptococcus constellatus 3 (10.3) 9 (19.6) 0,3491 12 (16.0)
Streptococcus dysgalactiae ssp. equisimilis 0 (0) 1 (2.2) 1.0000 1 (1.3)
Streptococcus pneumoniae 1 (3.4) 0 (0) 0.3867 1 (1.3)
Streptococcus pyogenes 2 (6.9) 1 (2.2) 0.5555 3 (4.0)
Haemophilus influenzae 9 (31.0) 6 (13.0) 0,0774 15 (20.0)
Haemophilus parainfluenzae 7 (24.1) 21 (45.7) 0.0864 28 (37.3)
Capnocytophaga sp. 1 (3.4) 2 (4.3) 1.0000 3 (4.0)
Candida sp. 6 (20.7) 4 (8.7) 0.1715 10 (13.3)
In addition to the listed species, in all patients bacteria of the physiological resident microflora could be detected.
doi:10.1371/journal.pone.0009452.t004
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PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9452Figure 1. UPGMA-tree of PFGE patterns and group-associated characteristics of S. aureus isolates from RT patients. The consensus
tree was constructed by interpreting PFGE-band patterns with help of the GelCompar
TM-Software (version 4.1, Applied Math) using the UPGMA
algorithm with Dice coefficients. Based on this consensus tree and taking the screened parameters listed in this table into account 6 clusters and a
group of ‘‘independent’’ or unrelated strains can be distinguished; Legend: in/ex–intracellular/extracellular location according to the antibiotic
protection assay, dark/grey fields denote the exclusive presence at the intra-/ extracellular location; cl–cluster number, in–independent strain, spa–
spa-type; spa CC–spa-clonal cluster; MLST–Multi-Locus-Sequence-Typing clonal clusters, MLST-CCs were deduced from BURP grouping of spa-typing;
ST–Sequence Type; penicillin–penicillin susceptibility (S-susceptible, R-resistant); invas. %–invasive character of the isolate in the FACS-based invasion
assay, cut off: ,20% value relative to the corresponding value of S. aureus strain Cowan I during the same series of experiments, grey fields denote
non-invasive strains; fnbB–fibronectin binding protein B; fib–fibrinogen binding protein; ebpS–elastin binding protein; cna–collagen binding protein;
bbp–bone sialoprotein binding protein, (note: 100% of the isolates were positive for clumping factor A & B (clfA, clfB) fibronectin binding protein A
(fnbA) and laminin binding protein (eno)), biofilm formation of the RT-associated S. aureus isolates in relation to S. aureus strain ATCC 25923; (The
different gray shaded boxes indicate groups of isolates with above average frequency of the certain parameter)
1 MRSA;
2 small colony variant.
doi:10.1371/journal.pone.0009452.g001
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range of non-invaded and invaded cells is defined by a
fluorescence of less than 1% and 55–75% of eukaryotic cells.
The contribution of extracellular adhering bacteria to the
fluorescence signal was found to be generally lower than 6% of
the tested cells. Setting the results of the positive control as 100%
and defining 20% of this value as the cut-off mark for non-
invasiveness, 85.5% (65/76) of the S. aureus strains eagerly
invaded A549 cells. The average relative internalization ratio
among these strains was 74% (631%). Since 57.7% (75/130) of
all RT patients were positive for S. aureus, 50% (65/130) of all RT
cases within the study population were associated with invasive S.
aureus isolates.
Biofilm formation. As shown in figure 1, none of the
tonsillar S. aureus isolates grew monospecies biofilms on uncoated
polystyrene surfaces, whereas the reference strain S. aureus ATCC
25923 was an excellent biofilm former in this experimental setup.
After coating the polystyrene surfaces with human collagen,
only 4 (5.2%) of the 76 strains demonstrated a moderate to good
(.20%) biofilm formation capability. In contrast fibronectin
coating enabled 62 (81.6%) of the 76 S. aureus isolates to form
considerable biofilm masses. However, 18.4% of the S. aureus-
isolates from RT patients did not grow biofilms neither on
uncoated nor on collagen- or fibronectin-coated surfaces.
Typing and MSCRAMM-gene detection data. Performing
PFGE on the 76 RT patient S. aureus isolates identified 65 different
PFGE types (figure 1). By setting the cut-off value at 80% for
defining unrelated individual strains, 24 different strains resulted
from this operation.
Spa-typing of the same S. aureus population resulted in 50
different spa-types which were clustered by BURP analysis into 11
different clonal complexes (spa-/MLST-CC). The constructed
consensus tree based upon these spa-types (figure 3) is, as expected,
different from the consensus tree derived from PFGE-typing.
However, there are clear correlations between the PFGE-deduced
clusters and the spa-/MLST-CCs (figure 1).
The results from the MSCRAMM gene detection by multiplex-
PCRs are also listed in figure 1. Of note, each S. aureus isolate
encoded the fnbA, clfA, clfB, eno and fnbA genes (data not shown)
and a majority carried the fib (74%) and fnbB (87%) genes. In
contrast, only a minority ranging between 30% and 45% of the
isolates harbored the ebpS, bbp, and cna genes.
Taking all screened parameters into account, we could
distinguish 6 clusters and 22 independent S. aureus isolates among
the RT patient strains (figure 1).
The first cluster consisted of 14 isolates (A02–G35) belonging to
the spa-/MLST-CC 30 or 121. Most of the isolates in this cluster
were penicillin resistant, positive for ebpS, cna and bbp genes and
able to form biofilms only after fibronectin coating.
The second cluster was formed by 10 isolates (G27–G19). In this
group the spa-/MLST-CCs 45 and 22 were overrepresented. Three
common characteristics of this cluster were penicillin resistance, cna-
gene presence, and biofilm formation on fibronectin-coated surfaces.
The third (G51–G76) and the fourth cluster (G29-G09) formed
a supercluster (G29–G76). The third cluster was characterized by
bbp-gene presence and above average susceptibility to penicillin.
The 11 isolates of this cluster predominantly belonged to the spa-/
MLST-CCs 25 and 1.
Of the 7 isolates of the fourth cluster, some were able to form
biofilms not only after fibronectin coating but also on collagen-
coated surfaces. Here the spa-/MLST-CCs 25 and 12 and
penicillin susceptibility were typical characteristics of the isolates.
The fifth cluster, which is also characterized by penicillin
susceptibility and biofilm growth only on fibronectin-coated
surfaces, has four members (A27–A15). In contrast to the isolates
of cluster three, these isolates did not harbor bbp and were
exclusively members of the spa-/MLST-CC 15.
Cluster six consists of 7 isolates (G64I–A55), most of them
devoid of ebps, cna and bbp. Frequent spa-/MLST-CCs were 30 and
8. The isolates exhibited above-average penicillin susceptibility.
The 21 independent isolates (A13–G91) not associable to one of
the described clusters belonged to a wide variety of spa-/MLST-
Table 5. Antimicrobial susceptibility of S. aureus isolates from RT patients and reference strains from different upper respiratory
tract-related outpatient clinics
1 of the Rostock University Hospital in the years 2001–2007.
n (%) susceptible S. aureus isolates
antibiotics
S. aureus strains of outpatients
with RT n=76
S. aureus strains of patients
from outpatient clinics
1 n=296 p-value
penicillin 25 (32.9) 70 (23.6) 0.1063
Oxacillin 75 (98.7) 296 (100) 0.2043
cefuroxime 75 (98.7) 296 (100) 0.2043
levofloxacin 75 (98.7) 285 (96.3) 0.4724
moxifloxacin 75 (98.7) - -
gentamicin 75 (98.7) 285 (96.3) 0.4724
streptomycin 66 (86.8) - -
erythromycin 70 (92.1) 271 (91.6) 1.000
teicoplanin 76 (100) 296 (100) 1.000
vancomycin 76 (100) 296 (100) 1.000
cotrimoxacol 76 (100) 293 (99.0) 1.000
doxycycline 71 (93.4) 260 (87.8) 0.2181
clindamycin 76 (100) 284 (95.9) 0.1366
1The material was collected from outpatients presenting at the otolaryngology, ophthalmology, and oral and maxillofacial surgery clinics.
doi:10.1371/journal.pone.0009452.t005
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PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9452Figure 2. S. aureus invasion of human A549 lung carcinoma cells. Shown are the original dot plots of representative flow cytometric analyses
of CFSE-labeled bacteria after addition of 0.2% trypan blue. The percentage of cells containing intracellular staphylococci is written in the upper right
corner of the plot. (A) S. aureus strain Cowan I–positive control strain with good invasion (100%); (B) S. carnosus–negative control strain showing no
invasion, The percentage of cells containing intracellular S. carnosus is subtracted from that of all other Staphylococcus isolates including the Cowan I
control (0%); (C) S. aureus isolate A7–highly invasive strain (172.3% of Cowan I); (D) S. aureus isolate G86–cell internalization rate comparable to the
positive control strain (107.8% of Cowan I); (E) S. aureus isolate G76–very low invasive strain (24.7% of Cowan I); (F) S. aureus isolate G43–non-invasive
strain (9.2% of Cowan I, below 20%).
doi:10.1371/journal.pone.0009452.g002
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mostly penicillin-resistant and negative for ebps, cna and bbp. Many
of them are poor biofilm formers even on fibronectin-coated
surfaces.
Isolate G87 was a single offshoot in the PFGE- consensus tree,
but was associated with isolates A26 and G19 in the spa-/MLST-
CC 22.
Immunohistology and FISH. For immunohistology and
FISH we chose specimen of these 13 patients, where only S. aureus
and no other bacteria could be grown from the tonsillar tissue.
Results from the immunohistologic examination of the tonsil
sections from these S. aureus positive patients are displayed in
figure 4. The microscopic pictures clearly show the association of
S. aureus-specific staining with histological signs of inflammation
like epithelial defects, granular exsudate, necrosis and loose
epithelia and thereby demonstrate that S. aureus was not a simple
transient colonizer at the specific anatomic space.
In parallel, FISH performed on paraformaldehyde fixed tonsil
sections also demonstrated the presence of S. aureus-specific signals
(figure 5). For easier comprehension, the fluorescence signal
components of the superimposed pictures (line 4) are shown in
lines 1 to 3. Thus, the photographs in columns A to C show a
cluster of S. aureus bacteria within a tonsillar crypt, a small group of
S. aureus cells in the upper left corner (of note, erythrocytes did not
bind the DAPI-stain, but unspecifically the eubacterial and the S.
aureus probes) and the polymicrobial nature of recurrent tonsillitis,
respectively. In column C, S. aureus (red to yellow) and other
eubacteria (green) can be clearly distinguished.
The proximity of some bacterial signals to signals from
eukaryotic nuclei indicated an intracellular localization of such
bacteria.
Discussion
The main objective of the present study was to clarify why RT
cases caused by persisting bacterial pathogens often cannot be
cured by administration of antibiotics but have to be treated by
tonsillectomy. For this purpose, we performed a prospective study
with carefully chosen patients suffering from RT or PTA and
analyzed not only the presence of microbial pathogens from a
variety of patient specimens but also examined crucial molecular
data as well as biological functions of the identified bacteria.
Regarding patient numbers, inclusion criteria, and conventional
bacteriological analysis the present study is comparable to several
studies on RT patients [11–14,16–18,20] and on PTA patients
[6,7,9] conducted in the last twenty years. However, none of these
studies addressed the biological capabilities, i.e. biofilm formation
or eukaryotic cell internalization, of the bacteria in situ or after
isolation. Also, analysis of the clonal diversity of the identified
bacteria has not been performed so far.
Consistent with the majority of former studies, S. aureus and
Haemophilus spp. were preferentially associated with RT patients
[11,12,14,19-21,43]. Similarly, S. pyogenes was the leading single
species in material from PTA patients, although much less
prominent than previously described [6-8]. Comparatively low
isolation rates for S. aureus and/or high isolation rates for S. pyogenes
from RT patients as described in some studies [10,13,17,18,44]
could be due to geographical or seasonal effects [25], a selective
panel of detection methods, or to temporal variations as described
by Timon et al. [20]. In agreement with Lindroos [15], we would
state that the impact of S. pyogenes in RT pathogenesis has probably
been overrated or, alternatively, has decreased in recent years.
A clear advantage of the present study is the inclusion of both
children and adults. In contrast to three other studies analyzing both
age groups [14,16,17], the results were separately evaluated.
Noteworthy, children and adults did not differ in the prevalence of
single pathogens and to mixtures of pathogens (tables 3 and 4). This
indicates that the causative pathogen/-s has/-ve a major impact on
pathogenesis and that age-dependent variation of eukaryotic target
structures for the identified pathogens is not relevant. Similar to
Jeong et al., who analyzed the prevalence of multiple pathogens
Figure 3. Consensus tree showing the genetic relatedness of
the 76 S. aureus tonsillar isolates. The 50 spa-types were clustered
by BURP analysis into 11 clonal complexes. For construction of the
consensus tree, several reference strains were included in the BURP
clustering. The most common spa-type is t056 (n=8). MLST clonal
clusters were deduced from BURP grouping of spa-types.
doi:10.1371/journal.pone.0009452.g003
S. aureus Caused Tonsillitis
PLoS ONE | www.plosone.org 9 March 2010 | Volume 5 | Issue 3 | e9452[14], S. aureus and Haemophilus spp. were often co-isolated in RT
patients, especially in adults. Unlike that study, also the Streptococcus
anginosusgroup displayed a highdegreeofassociationwithS.aureusin
RT patients. To date, there is not sufficient information available to
decide whether these associations rely on symbiotic effects or rather
reflect the absence of interference mechanisms similar to those
observed between colonizing S. aureus and Streptococcus pneumoniae
strains in the upper respiratory tract [45-47].
Figure 4. Microscopic aspect of RT-associated tonsillar specimen subjected to immunohistochemistry. S. aureus-bacteria were marked
by the APAAP staining technique. A: base of a tonsillar crypt (x200) B: necrosis (x200) C: tonsillary epithelium (x1000). These photographs
demonstrate that RT-associated S. aureus isolates are involved in pathological processes and are not transient colonizers.
doi:10.1371/journal.pone.0009452.g004
Figure 5. Microscopic aspect of RT-associated tonsillar specimen subjected to fluorescence-in-situ-hybridization. FISH-probes: green
(FITC) - eubacteria, red (Cy3) - S. aureus, yellow: merge, blue (DAPI): nucleic acids; Column A 1–4: (x1000) cluster of S. aureus bacteria wihin a tonsillar
crypt. Column B 1–4: (x1000) few S. aureus bacteria in the upper left corner of the photograph. Of note, the FISH-probes bound unspecifically to
erythrocytes, which in turn miss DAPI-fluorescence (no nuclei). Column C 1–4: (x1000) the proximity of some S. aureus bacteria to the DAPI-stained
nuclei strongly indicate an intracellular localization. The presence of green-fluorescing non-S. aureus-bacteria indicate the status of a polymicrobial
infection.
doi:10.1371/journal.pone.0009452.g005
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species associated with RT patients, we asked whether there are
RT specific S. aureus strains. Utilizing two independent methods of
molecular typing, we could show a large genomic diversity among
the RT-associated S. aureus strains, which was especially remark-
able since the patients were recruited from a comparatively small
and stable population of about 350.000 inhabitants. Obviously,
the capability to cause RT is not confined to a few specifically
adapted or equipped S. aureus strains.
The next question addresses the potential source of such strains.
By comparing the spa-derived clonal complex (CC) types of our
isolates with those from S. aureus strains obtained from healthy
nasal carriers in the same geographic region in 2005/06
[48][table 6], we observed a strong overlap in the population
structure. This finding suggests that the RT-associated S. aureus
strains originated from nasal carriage and thus, caused endoge-
nous infections. Consistently, 10 to 35% of asymptomatic adults
have been described as persistent nasal S. aureus carriers [49] and
at least in some settings, pharyngeal carriage rates could be even
higher [50].
After describing the genetic background of the RT-associated S.
aureus strains, the major issue of this study was addressed–i.e.
providing an explanation for the strains’ successful persistence in
their hosts in spite of repeated antibiotic therapies. Antibiotic cross
protection [20,22] is an improbable mechanism, since the majority
of S. aureus isolates displayed at least resistance to penicillins and
the co-isolated pathogens were less frequently producers of
extracellular b-lactamases than the S. aureus strains (data not
shown). Inadequate, since predominantly S. pyogenes-directed
therapy remains a formal possibility in some cases. Biofilm
formation on the tonsillar surfaces cannot be completely excluded
as an explanation. At least in specific skin infections, S. aureus has
been demonstrated in intra-tissue biofilm-like masses [51].
However, the almost complete absence of this capability in our
S. aureus strains growing on polystyrene or collagen surfaces as well
as the absence of material resembling biofilms on selected tonsils as
determined by scanning electron microscopy (data not shown) are
valid arguments against a leading role of biofilms in RT
pathogenesis. Similarly, by using in situ hybridization Swidsinski
et al. [32] could demonstrate biofilm-like masses on surgically
removed tonsils, but were unable to identify S. aureus in these
masses.
In contrast, intracellular persistence as the major principle is
supported by several experiment-based arguments: first, .90%
of S. aureus strains were isolated from tonsillar cells (usually white
blood cells residing there) by an antibiotic protection assay,
.85% of these strains displayed a high degree of internalization
in a FACS-based in vitro assay, and the complete subset of
strains subjected to FISH and immunoassay-based microscopy
of ex vivo material was detected in nucleus-near positions
typical for an intracellular status. Consistent with these
observations, the molecular analysis confirmed the presence of
up to 9 established adhesin genes in the RT-associated S. aureus
strains, among them the ones encoding the well-known adhesins
FnbA and FnbB involved in eukaryotic cell internalization
[40,52–54]. However, also all of the in vitro less invasive isolates
harbored the fnbA gene and varying sets of other adhesin genes,
t h u sn o ta l l o w i n gas i m p l ed i f f e rentiation based on limited
genetic analysis.
Which impact has eukaryotic cell internalization on long-term
persistence of S. aureus in the upper respiratory tract of its human
host? In vitro internalization capacity, although on a much lower
level, has also been demonstrated for few strains involved in nasal
colonization [52]. Additionally, in vitro bacterial transcriptome
changes supporting intracellular persistence in respiratory epithe-
lial cells have been studied to great detail [55]. Using ex vivo
material from chronic rhino-sinusitis patients, Clement et al. [37]
and Plouin-Gaudon et al. [38] convincingly demonstrated
intracellular S. aureus in 17 out of 27 cases. However, the role of
S. aureus in chronic rhinosinusitis is not well defined [56-58]. Also
in our study, the relative contribution of intracellular S. aureus to
clinical persistence is not completely clear. Additional ex vivo and
in vitro comparative analysis of the internalization status of S.
aureus strains exclusively associated with acute infections could
Table 6. Comparison of spa-CC–prevalences of S. aureus isolates from RT patients and healthy persons with nasal colonization.
spa-CC RT-isolates nasal isolates [Holtfreter et al. 2007]
No. of isolates % No. of isolates % p-value
CC1 2 2.6 0 0.0 0.1711
CC5 4 5.3 7 6.5 1.0000
CC8 4 5.3 11 10.3 0.2807
CC12 5 6.6 2 1.9 0.1288
CC15 12 15.8 13 12.1 0.5172
CC22 3 3.9 2 1.9 0.6505
CC25 14 18.4 14 13.1 0.4052
CC30 13 17.1 29 27.1 0.1532
CC45 6 7.9 11 10.3 0.7969
CC121 3 3.9 0 0.0 0.0700
CC395 1 1.3 5 4.7 0.4031
singletons 6 7.9 10 9.3 0,7964
excluded 3 3.9 3 2.8 0.6937
total 76 100 107 100 -
Legend: spa CC–spa-clonal cluster.
doi:10.1371/journal.pone.0009452.t006
S. aureus Caused Tonsillitis
PLoS ONE | www.plosone.org 11 March 2010 | Volume 5 | Issue 3 | e9452introduce new arguments. Yet, even a high degree of cell
invasiveness of such strains would not contradict the importance
of that feature for persistence [59].
Which consequences for an alternative antibiotic treatment
could be delineated from our results? Contrary to observations on
intracellular S. pyogenes strains [60], the RT-associated S. aureus
isolates displayed less often resistance to antibiotics as compared to
the PTA-associated strains or those isolated from outpatients of
several clinics (table 5). Probably, in S. aureus the presence of
resistance genes is not coupled to invasin genes as postulated for S.
pyogenes.
A less frequent occurrence of antibiotic resistance traits could
be explained with the protected status of intracellular bacteria,
which in turn decreases the selective pressure of antibiotics.
Under such circumstances loss of resistance traits should
predominantly depend on the duration of the protected status
[61,62]. Yet, the difference between the antibiotic resistance
ratios of RT-associated and other S. aureus strains was not
significant for any tested compounds. Still, every RT-associated
isolate was susceptible to clindamycin. This drug has success-
fully been used for eradication of S. pyogenes strains involved in
recurrent infections [63,64] and thus, might as well prove useful
to fight intracellular RT-associated S. aureus strains. That
approach was in fact recommended more than 20 years ago
[65] and should now be tested on a larger scale. Alternatively,
quinupristin-dalfopristin and oritavancin have been described as
active on intracellular S. aureus [66]. In fact, selected RT-
associated S. aureus isolates proved to be fully susceptible to the
streptogramin (data not shown), a finding that could extend the
therapeutic options. But it should be also taken into consider-
ation that clinical symptoms could also be due to the co-
infection with other bactera like Haemophilus sp., because in only
about one fifth of the RT patients S. aureus was the only isolated
pathogenic agent.
In conclusion, the present study demonstrates that the majority
of RT cases both in children and adults are most probably caused
by intracellular persisting S. aureus strains and gives experimental
data-based indications for an alternative pharmaceutical therapy
to avoid surgery and its complications.
Materials and Methods
Patients and Statistics
The 254 prospectively recruited participants were juveniles and
adults of 1 to 76 years of age (median: 24 years), who were
surgically treated at the otolaryngology/head and neck surgery
department of the University Hospital Rostock, Germany, from
July 2001 until December 2007 because of clinical signs of RT or
PTA.
The diagnosis of RT has been based on an anamnestic report of
at least three episodes of purulent tonsillar infections and/or
odynophagia, tender cervical lymph nodes and pharyngeal pain in
the year before tonsillectomy. Criteria for inclusion in the PTA-
group were the aspiration of pus and/or persistent pain in the
peritonsillar area, trismus and unilateral tonsillar bulge.
General exclusion criteria for both groups were therapy with
any antibiotics beside penicillins and cephalosporins within the last
two weeks before surgery, severe liver dysfunction, malabsorption,
nephrotic syndrome, severe primary and acquired immunodefi-
ciency, hematologic system diseases, pregnancy and lactation.
After tonsillectomy, histological analysis of the specimens from
all patients was routinely performed to verify the clinical diagnosis.
This study was conducted following the approval of the
ethics commission of the Medical Association Mecklenburg-
Vorpommern (Reg.-no. II HV 17/2001). We got written
informed consent from all participants, which were involved in
our study.
Culture of Extra- and Intracellular Bacteria (Antibiotic
Protection Assay)
Immediately prior to surgery the tonsils were swabbed using
sterile wooden spatula (figure6 ) .T h es w a b b e dm a t e r i a lw a s
suspended in 10 ml phosphate buffered saline (PBS, pH 7.4)
a n dk e p ta t4 uC. The surgically removed tonsils were transferred
to 10 ml PBS and also kept at 4uC. All specimens were
transported in cooled containers and processed within two hours
after sampling.
Suspended tonsillar cells from the swabs were centrifuged for
10 min at 8006g and 4uC. After discarding the supernatant, cells
were resuspended in 1 ml fresh PBS. For subsequent FISH
analysis about 3630 ml of this cell suspension was streaked onto
three microscope slides.
In addition, 10 ml aliquots were used to inoculate sheep blood
and chocolate agar plates. The culture media were incubated over
night at 37uC under a 20% O2/5% CO2 atmosphere. The
remaining suspension was supplemented with streptomycin and
cefuroxime, both to final concentrations of 100 mg/ml, and
incubated for 3 h at 37uC under ambient air to kill extracellular
bacteria while not affecting intracellular bacteria ([36,67], see also
below for control experiments).
Upon arrival in the laboratory, surgical tonsil specimens were
cut in small pieces using sterile instruments. About half of the
tissue was fixed in formalin, dehydrated an embedded into a
paraffin matrix for histology. The remaining tonsil tissue pieces
were immersed in 1 ml PBS and vortexed. Ten ml aliquots from
the crude suspension were plated and cultured as described for the
untreated cell suspensions. To achieve a homogenous cell
suspension and best possible access for antibiotic supplements,
the remaining crude suspensions were supplemented with
collagenase I-solution (Sigma) to a final concentration of
100 mg/ml (12500 collagen digestion units/ml) and the above
described antibiotics, incubated and further processed like the
swab-derived cell suspensions.
After 3 hrs of incubation the cells were disrupted by exposure to
ultrasound (Bandelin Electronic UW2200) and subsequent hy-
poosmolar conditions. The lysates were cultured on solid media
like the untreated cell suspensions.
To verify the thorough killing of extracellular bacteria under
the conditions chosen for the antibiotic protection assay, varying
numbers of S. aureus ATCC 25923 were added to subconfluent
HEp-2 cell monolayers (multiplicity of infection, MOI: 0.01-
100) and allowed to internalize for periods between one to four
hours. Antibiotics were added at above described concentrations
after 0 to 120 minutes to the co-cultures and allowed to react for
periods up to four hours. The eukaryotic host cells were
mechanically suspended and bacteria were quantified with
respect to their extra- or intracellular location. At antibiotic
exposure periods of three hours consistently no extracellular
bacteria could be detected, while the amount of intracellular
bacteria increased with respect to the initial inoculum and the
coincubation period.
As an additional control suspensions from three tonsil
preparations were spiked with 100 mlo fS. aureus ATCC 25923
suspension containing 0.5610
4 CFU/ml and processed as above.
While the inoculated bacteria could be detected in absence of
antibiotics, no S. aureus was cultured from an extracellular location
after the full exposure period to the antibiotics.
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Identification of bacterial species was performed using estab-
lished methods of the accredited diagnostic laboratory. All
pathogenic strains were stored at –80uC in microbank tubes
(Pro-lab Diagnostics) utilizing isolates from the first laboratory
passage.
S. aureus was identified by the Pastorex Staph-Plus latex
agglutination kit (BIO-RAD). Sero-types of b-hemolysing strepto-
cocci were determined by the Pastorex Strep latex agglutination
test (BIO-RAD). The species identification of such streptococci
was achieved by 16S rRNA gene sequence analysis. Other
bacterial species were differentiated using the Vitek 2 device or
appropriate API-systems (bioMe ´rieux).
Antibiotic resistance tests of S. aureus isolates were performed
with penicillin (10 mg), oxacillin (1 mg), cefuroxime (30 mg),
levofloxacin (5 mg), gentamycin (10 mg), streptomycin (10 mg),
erythromycin (15 mg), teicoplanin (30 mg), vancomycin (30 mg) and
cotrimoxacole (1,25/23,75 mg) using a disc diffusion method on
Mueller-Hinton agar (Oxoid) according to the CLSI (Clinical and
Laboratory Standards Institute) directives (M100-S17M2-A9).
MICs of moxifloxacin and clindamycin were determined by the
E-test method (AB BIODISK).
Pulsed-Field Gel Electrophoresis
Molecular typing to demonstrate the epidemiological relation of
the isolated S. aureus strains was performed by pulsed-field gel
Figure 6. Flow chart illustrating the processing of tonsillar specimens as described in the ‘‘Materials and Methods’’-section.
doi:10.1371/journal.pone.0009452.g006
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endonuclease SmaI (Roche) by using a CHEF-DR III Pulsed Field
Electrophoresis System (BIO-RAD) according to established
protocols [68] with minor modifications using following settings -
initial switch time: 5 sec., final switch time: 35 sec., voltage:
5.5 V/cm, included angle: 120u run time: 22 h.
The chromosomal DNA restriction patterns were interpreted
with help of the GelCompar
TM-Software (version 4.1, Applied
Math) using the UPGMA algorithm with Dice coefficients.
According to this program and the criteria of Tenover et al.
[69], strains with PFGE pattern relatedness below 80% were
regarded as different clones.
DNA Extraction, Spa-Typing and MSCRAMM-Multiplex-
PCR
Bacterial genomic DNA was purified using QIAamp DNA Mini
Kit (Qiagen). Spa-typing was performed by amplification and
sequencing of the variable X region of the spa-gene. Obtained
forward and reverse sequence chromatograms were analyzed
using the Ridom StaphType software (http://spaserver.ridom.
de/, Ridom) [70]. Spa-types were clustered into different groups by
the BURP algorithm.
The presence of MSCRAMM-genes in the S. aureus isolates
was monitored by a multiplex PCR as described by Tristan et al.
[39]. Two primer sets (PCR1: bbp, cna, ebpS and eno;P C R 2 :fnbA,
fnbB, fib, clfA and clfB)w e r eu s e df o rm u l t i p l e xP C R .T h e
thermal cycling conditions included preincubation at 94uCf o r
5 min followed by 25 cycles of denaturation at 94uCf o r1m i n ,
annealing at 55uC for 1 min and extension at 72uCf o r1m i n ,
with a final extension of 72uC for 10 min. PCR products were
analyzed on 1% agarose gels and stained with ethidium
bromide.
Flow Cytometric Internalization Assay
A well-established and widely used FACS-based internalization
assay was performed as described previously [71] using a
FACSCalibur (Becton Dickinson) and the following modifications.
Subconfluent monolayers of human A549 lung carcinoma cells
(DSMZ) grown in DMEM/10% calf serum were inoculated with
the respective 5-(6)-caboxyfluoresceinsuccinimidylester stained
(CFSE; Sigma-Aldrich) S. aureus-strain at a multiplicity of infection
(MOI) of 30. The fluorescence signal of adherent but not
internalized bacteria was quenched by adding 0.2% trypan blue
(Sigma-Aldrich) to each sample before measurement. The non-
invasive S. carnosus strain TM300 (ATCC 51365) was used as
negative control to define the background of the fluorescence
signal. S. aureus strains that showed less than 20% invasiveness
comparing to the reference strain Cowan I (ATCC 12598) were
defined as non-invasive [52,53].
Biofilm Analysis
Assays to quantify staphylococcal biofilm formation while
maintaining the bacteria in trypticase soy broth (TSB) are widely
established [72,73]. The biofilm experiments were performed in
96-well polysterene microtiter plates (Greiner). The well surfaces
were used either uncoated or coated with human fibronectin
(Roche) or human collagen type I (Biomol). Coating was
performed overnight at 4uC with the matrix molecules at
concentrations of 50 mg/ml. Unbound matrix molecules were
removed by three washes with PBS.
Precultures were obtained by direct inoculation of the tonsillar
S. aureus isolates into a 1 ml trypticase soy broth (TSB, Oxoid) and
incubation overnight at 37uC. Then the bacteria were harvested
by centrifugation, resuspended in TSB to an optical density (OD
600 nm) of 0.5 and 100 ml of this suspension containing 10
4 CFU/
ml were inoculated into each well. Planktonic bacteria were
removed by aspiration of the medium after 24 h or 48 h
incubation and biofilms were stained with 0.1% safranin after
washing twice with PBS. The OD 492 nm of the stained biofilms
was determined according to Lembke et al. [74].
Analyses were performed on three independent occasions and
two technical replicates with each isolate. Results are shown as
mean values of all experiments. The excellent biofilm forming S.
aureus strain ATCC 25923 [75] and the biofilm negative S. carnosus
strain TM300 (ATCC 51365) [76] were used as references.
Immunohistochemistry
Immunohistochemical assays were performed on formalin-
fixed, paraffin-embedded, then deparaffinized and rehydrated
1 mm sections of the tonsillar tissue samples as described by
Guarner et al. [77] using the polyclonal rabbit anti-S. aureus
antibody (BIODESIGN International) as primary antibody and
the APAAP staining technique (DAKO Cytomation).
Fluorescence In Situ Hybridization (FISH)
FISH was carried out as described by Krimmer et al. [78]
with minor modifications. Briefly, for deparaffination the tissue
sections were treated twice with xylene and then with xylene-
ethanol (1:1). For permeabilization, the bacteria were treated
with 200 mg/l lysostaphin and 12.5 mg/l lysozyme in PBS/
0.05% Triton-X-100. In situ hybridization of bacteria was
performed using the following oligonucleotides: EUB-338
59-GCT-GCC-TCC-CGT-AGG-AGT-39 FITC-labeled (eubac-
terial probe; [79]) and Sau-69 59-GAA-GCA-AGC-TTC-TCG-
TCC-G-39 Cy3-labeled (S. aureus–probe; [80]). Both probes
were synthesized by Eurogentec. VectashieldH Mounting
Medium with DAPI (Vector laboratories) was used on
hybridized slides. Finally, the slides were analyzed with a
BX60 fluorescence microscope (Olympus).
Supporting Information
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